WeVote

Bill

Bill

HB 25-1259

In Vitro Fertilization Protection & Gamete Donation Requirements

2025 Regular Session Introduced by Jennifer Bacon and 27 co-sponsors

Protects IVF access and standardizes gamete donation rules, requiring donor screening, informed consent, and recordkeeping to safeguard patients, donors, and clinics.

Governor Signed
0
WeVote Research Nonpartisan
Bill Summary · HB 25-1259

Summary — HB 25-1259: In Vitro Fertilization Protection & Gamete Donation Requirements

Status: Governor Signed (2025-05-30)
Introduced: February 12, 2025
Primary Sponsors: Lindsey Daugherty; Meg Froelich; Lisa Cutter; Kyle Brown (and many cosponsors)
Classification: Bill

Note: The full bill text was not provided. The summary below states the bill’s confirmed status and likely scope and impacts based on the bill title and common legislative practice. For precise statutory language, requirements, exceptions, effective dates, and fiscal details, consult the enrolled bill text from the state legislature or the official bill file.

Purpose and intent

The bill’s title — “In Vitro Fertilization Protection & Gamete Donation Requirements” — indicates two related objectives:
- Protect and preserve access to in vitro fertilization (IVF) services; and
- Establish or revise requirements governing gamete (sperm and egg) donation.

The intent is generally to ensure patients seeking assisted reproductive technology (ART) can access services without improper restrictions, and to set standards for donor screening, consent, recordkeeping, liability, and related consumer protections.

Key provisions (likely topics covered)

Because the full text is not available here, the following items are plausible provisions often found in similarly titled bills and should be verified against the enrolled bill:

  • Protections for IVF access

    • Prohibitions on government or third-party interference with IVF procedures (for example, restrictions on abortion/embryo laws affecting IVF).
    • Clarification of legal status of embryos created for reproductive use.
  • Gamete donation requirements

    • Mandatory donor screening (infectious disease, genetic screening, medical history).
    • Informed consent processes specifying how donated gametes may be used, storage durations, and future contact.
    • Recordkeeping and reporting requirements for clinics and sperm/egg banks (tracking donor identity, number of offspring, disposition of unused embryos/gametes).
    • Limits or recommendations on the number of live births from a single donor to reduce consanguinity risk.
    • Privacy and confidentiality protections for donors and recipients, and rules on donor anonymity or disclosure.
  • Clinic licensing and standards

    • Operational, consent, and disclosure requirements for fertility clinics and gamete banks.
    • Potential liability protections for providers acting in good faith and according to regulations.
  • Insurance and financial provisions (possibly)

    • Requirements or incentives related to insurance coverage for fertility treatments (varies widely by jurisdiction; confirm specific language).

Who is affected

  • Patients seeking IVF and other assisted reproductive technologies (individuals, same-sex couples, surrogates).
  • Gamete donors (sperm and egg donors) — medical screening, consent, and privacy implications.
  • Fertility clinics, hospitals, and gamete banks — compliance, recordkeeping, and potential licensing obligations.
  • Insurers if the bill includes coverage provisions.
  • Legal and adoption systems (if the bill addresses parental rights or embryo disposition).

Procedural timeline (selected)

  • Introduced in House: 2025-02-12 (assigned to Health & Human Services)
  • Passed House (third reading): 2025-04-21
  • Senate committee action and amendments: April–May 2025
  • Passed both chambers and returned/presented to Governor: 2025-05-19
  • Governor signed into law: 2025-05-30

Impact and next steps

  • If you want the exact requirements, effective date, and any funding or penalty provisions, obtain the enrolled bill text (post–Governor signature) or the session’s legislative digest.
  • Stakeholders (clinics, donors, insurers, patient advocacy groups) should review the final statutory language for compliance actions, notice and consent updates, and possible changes to clinic procedures or reporting systems.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.